Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,220.04
1,279.64
1,177.88
1,015.03
1,049.99
784.36
501.47
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,220.04
1,279.64
1,177.88
1,015.03
1,049.99
784.36
501.47
Raw Material Cost
650.52
584.37
556.66
411.41
483.87
372.04
197.72
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
307.30
275.97
0.00
0.00
136.34
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
63.87
53.79
44.73
25.02
11.28
3.15
0.48
Selling and Distribution Expenses
229.34
207.95
167.50
168.00
145.32
84.21
75.78
Other Expenses
21.56
21.95
-12.33
-11.35
14.94
12.52
-2.44
Total Expenditure (Excl Depreciation)
1,159.36
1,065.62
952.94
766.93
789.82
584.62
385.92
Operating Profit (PBDIT) excl Other Income
60.7
214
224.89999999999998
248.1
260.2
199.7
115.5
Other Income
42.85
37.29
48.25
49.02
28.21
13.32
13.86
Operating Profit (PBDIT)
247.33
347.94
336.22
341.10
329.50
235.91
154.96
Interest
63.87
53.79
44.73
25.02
11.28
3.15
0.48
Exceptional Items
10.66
-10.08
-0.52
-3.39
0.79
0.04
0.00
Gross Profit (PBDT)
569.52
695.27
621.22
603.61
566.11
412.33
303.75
Depreciation
167.61
117.70
88.59
61.56
52.32
39.24
33.38
Profit Before Tax
26.53
166.36
202.38
251.12
266.69
193.56
121.10
Tax
-23.05
15.94
15.35
30.78
19.90
21.96
8.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
54.51
189.17
202.47
239.62
243.95
169.88
111.08
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
54.51
189.17
202.47
239.62
243.95
169.88
111.08
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-17.56
-47.90
-29.04
-28.20
-6.39
-0.52
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
36.95
141.26
173.42
211.43
237.56
169.36
111.08
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,521.17
2,383.30
2,368.62
2,191.64
1,678.19
1,431.78
1,313.09
Earnings per share (EPS)
0.13
0.45
0.48
0.58
0.59
0.41
0.27
Diluted Earnings per share
0.13
0.45
0.48
0.58
0.59
0.41
0.27
Operating Profit Margin (Excl OI)
3.02%
15.08%
16.93%
22.71%
23.71%
23.38%
21.48%
Gross Profit Margin
15.91%
22.2%
24.7%
30.81%
30.38%
29.68%
30.81%
PAT Margin
4.47%
14.78%
17.19%
23.61%
23.23%
21.66%
22.15%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -4.66% vs 8.63% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -73.81% vs -18.51% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -34.18% vs 7.88% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 18.77% vs 20.36% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of BrightGene Bio-Medical Technology Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,220.04
0
1,220.04
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,220.04
0
1,220.04
Raw Material Cost
650.52
0
650.52
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
63.87
0
63.87
Selling and Distribution Expenses
229.34
0
229.34
Other Expenses
21.56
0.00
21.56
Total Expenditure (Excl Depreciation)
1,159.36
0
1,159.36
Operating Profit (PBDIT) excl Other Income
60.68
0.00
60.68
Other Income
42.85
0
42.85
Operating Profit (PBDIT)
247.33
0
247.33
Interest
63.87
0
63.87
Exceptional Items
10.66
0
10.66
Gross Profit (PBDT)
569.52
0
569.52
Depreciation
167.61
0
167.61
Profit Before Tax
26.53
0
26.53
Tax
-23.05
0
-23.05
Provisions and contingencies
0
0
0.00
Profit After Tax
54.51
0
54.51
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
54.51
0
54.51
Share in Profit of Associates
0
0
0.00
Minority Interest
-17.56
0
-17.56
Other related items
0.00
0.00
0.00
Consolidated Net Profit
36.95
0
36.95
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,521.17
0
2,521.17
Earnings per share (EPS)
0.13
0
0.13
Diluted Earnings per share
0.13
0
0.13
Operating Profit Margin (Excl OI)
3.02%
0%
0.00
3.02%
Gross Profit Margin
15.91%
0%
0.00
15.91%
PAT Margin
4.47%
0%
0.00
4.47%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 122.00 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -4.66% vs 8.63% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 3.70 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -73.81% vs -18.51% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.45 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -34.18% vs 7.88% in Dec 2024
Annual - Interest
Interest 6.39 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 18.77% vs 20.36% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.02%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
